Thermo Fisher Scientific Inc.

TMO · NYSE · Stock · Healthcare
$673.98
+1.65% today
Delayed price,

What Thermo Fisher Scientific does

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Key facts

Sector
Healthcare
Industry
Diagnostics & Research
Market cap
$249.20B
P/E (ttm)
36.3
Forward P/E
24.4
Dividend yield
0.28%
Beta
0.88
Profit margin
15.0%
Employees
125,000
Headquarters
Waltham, MA, United States
Exchange
NYSE

Performance

1 Month
+3.5%
3 Months
+26.6%
6 Months
+28.0%
1 Year
+25.1%
5 Years
+6.5%
$435.2752-week range$694.33
Biggest setback — last 12 months
-30.0%
19 Jan 2026 → 11 May 2026
Fell from $625.98 to $438.34 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+54.0%
11 May 2026 → 21 Sept 2026
Ran from $438.34 to $675.00 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▲ Trend: Uptrend
Price is above its 20-, 50- and 200-day averages, each stacked above the next — a classic technical uptrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$619.95 (-8.0%)$673.98$732.72 (+8.7%)
3 Months$583.16 (-13.5%)$673.98$778.94 (+15.6%)
6 Months$549.23 (-18.5%)$673.98$827.07 (+22.7%)
12 Months$504.58 (-25.1%)$673.98$900.25 (+33.6%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 28.9%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.